Loss of SIRT3 Provides Growth Advantage for B Cell Malignancies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Loss of SIRT3 Provides Growth Advantage for B Cell Malignancies

Published:2016-02 Issue:7 Volume:291 Page:3268-3279
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Yu Wei,Denu Ryan A.,Krautkramer Kimberly A.,Grindle Kreg M.,Yang David T.,Asimakopoulos Fotis,Hematti Peiman,Denu John M.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference52 articles.

1. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997;Harris;Ann. Oncol,1999

2. Chronic lymphocytic leukemia: staging and prognostic factors;Zwiebel;Semin. Oncol,1998

3. Biology and treatment of chronic lymphocytic leukemia;Keating;Hematology Am. Soc. Hematol. Educ. Program,2003

4. Chronic lymphocytic leukemia;Chiorazzi;N. Engl. J. Med,2005

5. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase;Imai;Nature,2000

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of SIRT3 in homeostasis and cellular health;Frontiers in Cellular Neuroscience;2024-08-02

2. Sirtuin insights: bridging the gap between cellular processes and therapeutic applications;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-07-08

3. Pharmacological Activation of SIRT3 Modulates the Response of Cancer Cells to Acidic pH;Pharmaceuticals;2024-06-20

4. Imperative connotation of SODs in cancer: Emerging targets and multifactorial role of action;IUBMB Life;2024-04-10

5. Targeting Hypoxia-Inducible Factor-1 (HIF-1) in Cancer: Emerging Therapeutic Strategies and Pathway Regulation;Pharmaceuticals;2024-02-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3